MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Occlusion Within Device (1423)
|
Patient Problem
Therapeutic Response, Decreased (2271)
|
Event Date 04/03/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8596sc, serial (b)(4), implanted: (b)(6) 2009, explanted: (b)(6) 2018, product type: catheter.The main component of the system.Other relevant device(s) are: product id: 8596sc, serial/lot (b)(4), ubd: 14-may-2011, (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider (hcp) regarding a patient who was receiving 2000 mcg/ml baclofen at 1075 mcg/day via an implantable infusion pump for intractable spasticity and cerebral palsy.It was reported that the patient presented with withdrawal symptoms.It was reported the dose had been increased since the original implant.The hcp decided to replace the entire system.It was reported that the entire system was explanted on (b)(6) 2018.Upon the removal the catheter tip appeared to be occluded, but it was not tested.The catheter appeared to flow when cut.It was reported that the patient was not involved in a clinical study.It was reported the device would be returned to the manufacturer, and the device was replaced with a manufacturer's product.It was reported that the device was used with/in the patient for treatment.There was no patient death or injury, and the patient recovered without sequela.No rotor study or dye study was performed and the pump was explanted due to a therapy related issue.No further complications were anticipated/reported.
|
|
Manufacturer Narrative
|
Analysis of the pump found no anomalies.Analysis of the suture less connector catheter found coring-tears-cuts in the seal that meets the leak criteria.Analysis of the (b)(4) catheter found no significant anomaly (it was returned in segments).Recent fda coding changes offer limited options for medical device evaluation conclusion coding.Medtronic selected conclusion code (b)(4) because, although the device was operating within specifications, medtronic modified the specifications making this the closest code available with respect to this event.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|